bluebird bio, Inc. Current Foreign Tax Expense (Benefit)
bluebird bio, Inc. reported Current Foreign Tax Expense (Benefit) of $70.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2025-03-27
- bluebird bio, Inc. current foreign tax expense (benefit) for fiscal 2024 was $70.00K.
- bluebird bio, Inc. current foreign tax expense (benefit) for fiscal 2023 was -$126.00K, a 207.69% decline from fiscal 2022.
- bluebird bio, Inc. current foreign tax expense (benefit) for fiscal 2022 was $117.00K, a 54.65% decline from fiscal 2021.
- bluebird bio, Inc. current foreign tax expense (benefit) for fiscal 2021 was $258.00K, a 62.28% decline from fiscal 2020.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $70.00K 10-K · filed 2025-03-27 |
| 2023-12-31 | -$126.00K 10-K · filed 2025-03-27 |
| 2022-12-31 | $117.00K 10-K · filed 2024-09-13 |
| 2021-12-31 | $258.00K 10-K · filed 2023-03-29 |
| 2020-12-31 | $684.00K 10-K · filed 2023-03-29 |
| 2019-12-31 | $612.00K 10-K · filed 2022-03-04 |
| 2018-12-31 | $222.00K 10-K · filed 2021-02-23 |
| 2017-12-31 | $95.00K 10-K · filed 2020-02-18 |
| 2015-12-31 | $60.00K 10-K · filed 2018-02-21 |